3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Neoplasm Metastasis
8
Ovarian Neoplasms
5
Sarcoma
4
Neoplasms
4
Lymphoma, Non-Hodgkin
4
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Glioma
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Neoplasms by Site
2
Medulloblastoma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Liposarcoma
2
Histiocytosis, Langerhans-Cell
2
Hereditary Sensory and Autonomic Neuropathies
2
Interventions
fludarabine
25
Cyclophosphamide
20
Azacitidine
20
venetoclax
18
Specimen Handling
18
fludarabine phosphate
17
Mycophenolic Acid
14
Melphalan
14
Busulfan
14
Biopsy
14
Whole-Body Irradiation
13
Tacrolimus
12
Cytarabine
12
Granulocyte Colony-Stimulating Factor
10
decitabine and cedazuridine drug combination
9
Decitabine
9
Stem Cell Transplantation
8
Sirolimus
8
Injections
8
Filgrastim
8
Cyclosporine
8
Peripheral Blood Stem Cell Transplantation
7
Thiotepa
6
ruxolitinib
5
X-Rays
5
Idarubicin
5
Magnetic Resonance Spectroscopy
4
Cladribine
4
CPX-351
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
palbociclib
×
90 days
×
Clear all
No trials found.